by Noxolo Majavu | Business Day | 1 July 2024 | Jul 5, 2024 | Archive, July 2024
Life Healthcare's subsidiary, Life Molecular Imaging, has sub-licensed its radiotherapeutic products to Lantheus Holdings for $35 million.
Subscription Required
You must be a subscriber to access all of this content.
View Subscriptions
by Rishika Sadam | Reuters | 28 June 2024 | Jul 5, 2024 | Archive, June 2024
India will incentivise local GLP-1 drug manufacturing by 2026, targeting diabetes and obesity treatments, as Novo Nordisk's patent expires.
Subscription Required
You must be a subscriber to access all of this content.
View Subscriptions
